Literature DB >> 23616188

Hyperthyroidism and thyroid cancer risk: a population-based cohort study.

N-C Yeh1, C-W Chou, S-F Weng, C-Y Yang, F-C Yen, S-Y Lee, J-J Wang, K-J Tien.   

Abstract

AIM: Thyroid hormones regulate the rate of metabolism and affect the differentiation and growth of many tissues in the body. We investigated the association between hyperthyroidism and cancer risk in Taiwan. PATIENTS AND METHODS: A random sample of 1 000 000 individuals from Taiwan's National Health Insurance database was enrolled. We found 17 033 patients to have newly diagnosed hyperthyroidism between 2000 and 2005. These patients were recruited along with a match cohort of 34 066 patients without hyperthyroidism. Starting from index date, we followed up all patients for 4 years to identify those who developed cancer.
RESULTS: During the 4-year follow-up study, cancer was diagnosed in 1.23% of patients with hyperthyroidism and 1.02% of the member of the comparison cohort. Regression analysis showed that patients with hyperthyroidism were at greater risk of cancer incidence, especially thyroid cancer, compared the comparison cohort (HR: 1.213; 95% CI: 1.022-1.440; p<0.05 and HR: 7.355; 95% CI: 3.885-13.92; p<0.05, respectively). After adjusting for age, gender, diabetes mellitus, hypertension, hyperlipidemia, gout, geographic region, and income, patients with hyperthyroidism remained at increased risk of cancer incidence and thyroid cancer (Adjusted HR: 1.206; 95% CI: 1.015-1.433 and 6.803; 95% CI: 3.584-12.91, respectively) (both p<0.05). The longer the duration of hyperthyroidism, the greater the risk of thyroid cancer.
CONCLUSIONS: This 4-year follow up study suggests that patients with hyperthyroidism are at increased risk of cancer, especially thyroid cancer. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23616188     DOI: 10.1055/s-0033-1341474

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study.

Authors:  Cari M Kitahara; Dóra K Rmendiné Farkas; Jens Otto L Jørgensen; Deirdre Cronin-Fenton; Henrik Toft Sørensen
Journal:  J Clin Endocrinol Metab       Date:  2018-06-01       Impact factor: 5.958

2.  The prevalence of thyroid cancer in patients with hyperthyroidism.

Authors:  Fathimabeebi P Kunjumohamed; Noor B Al-Busaidi; Hilal N Al-Musalhi; Sulaiman Z Al-Shereiqi; Issa S Al-Salmi
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

3.  Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control study.

Authors:  Young Ae Cho; Sun-Young Kong; Aesun Shin; Jeonghee Lee; Eun Kyung Lee; You Jin Lee; Jeongseon Kim
Journal:  BMC Cancer       Date:  2014-11-24       Impact factor: 4.430

4.  No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study.

Authors:  Claudia Becker; Susan S Jick; Christoph R Meier; Michael Bodmer
Journal:  BMC Cancer       Date:  2015-10-16       Impact factor: 4.430

Review 5.  Does hyperthyroidism worsen prognosis of thyroid carcinoma? A retrospective analysis on 2820 consecutive thyroidectomies.

Authors:  Fabio Medas; Ernico Erdas; Gian Luigi Canu; Alessandro Longheu; Giuseppe Pisano; Massimiliano Tuveri; Pietro Giorgio Calò
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-01-22

6.  A national database analysis for factors associated with thyroid cancer occurrence.

Authors:  Joon-Hyop Lee; Sora Youn; Sohee Jung; Kwangsoo Kim; Young Jun Chai; Yoo Seung Chung; Won Seo Park; Kyu Eun Lee; Ka Hee Yi
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.